Knee Pain Patients Are Urged To Investigate Stem Cell Therapy Before Agreeing To Knee Replacement Surgery

DePuy Knee Lawsuit News

Knee replacement surgery is dangerous, expensive and has questionable benefits for seniors suffering from osteoarthritis

Monday, December 10, 2018 - As the baby boomer population ages, those suffering from osteoarthritis are hitting record numbers. In 2016, over 750,000 knee pain patients opted to undergo total knee replacement surgery to replace their arthritic knee, often with less than optimal results. A recent study by CNBC has found that knee replacement surgery on senior citizens with osteoarthritis pain is expensive and a waste of money, sometimes costing as much as $10,000. The study found that total knee replacement was often ineffective and left patients in more pain and with even less mobility than before the surgery. knee replacement surgery is now one of the most common surgical procedures performed in the United States. DePuy knee lawsuits filed with national expert lawyers handling DePuy knee lawsuit cases have seen the after effects of numerous recalls of defective medical devices.

According to CNBC, researchers at Johns Hopkins Medicine are extremely skeptical of doctors that prescribe knee replacement surgery as a first option. "(knee arthritis treatments may be) as simple as Advil to more sophisticated courses of physical therapy that will give most patients better results," researchers have concluded.

In the past, arthritis has been treated with non-surgical options to reduce and occasionally eliminate the pain. With today's proliferation of knee replacement medical devices, medication and therapy are seen as second choices to radical knee replacement surgery. Senior citizens that have been advised to undergo knee replacement surgery should know that there are other options. Prescription pain relievers, as well as targeted physical therapy, can provide temporary yet effective pain relief from osteoarthritis in the knees. A longer-term treatment to alleviate the pain and immobility caused by knee osteoarthritis is stem cell therapy. According to thrive MD in Vail Colorado, "Stem cell therapy for knees is a minimally invasive procedure that has the potential to decrease inflammation, halt the progression of the arthritic damage, repair joint cartilage, and delay or avoid knee replacement surgery." Osteoarthritis is a form of degenerative knee cartridge. As osteoarthritis progresses the knees protective padding gradually wears away eventually resulting in bone contact effects of which are knee instability and extreme pain.

Stem cell therapy offers seniors suffering from degenerative arthritic pain hope to avoid knee replacement surgery. Stem cell therapy attempts to regenerate worn out knee tissue. According to thrivemdvail.com, "Injection of progenitor cells, especially mesenchymal stem cells, has been shown to be a better strategy to repair degenerative cartilage than implantation of differentiated cells such as articular cartilage. Adult stem cells have a reliable potential to differentiate into cartilage, bone, fat or soft tissue. They also display the ability to home to areas of inflammation and degeneration, and to modify immune system activity that can favorably influence the surrounding cartilage in areas of damage."

Scientists in Europe have made significant progress in repairing knees damaged by degenerative osteoarthritis. Euronews.net reports that Italian scientist Andrea Lolli explained how the new therapy works: "The deteriorated area is filled with the molecules. These molecules are developed to verify if the treatment succeeds in improving or promoting tissue repair. There are already stem cells in the joint. What we do is use molecules that will act on these cells where it is damaged. When stimulated these cells create new, healthy, and stable tissues."

More Recent DePuy Knee Lawsuit News:

No-Cost, No-Obligation DePuy Lawsuit Case Review If You or a Loved One Suffered from DePuy Knee Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm won $197 million in three talcum powder ovarian cancer lawsuits in St. Louis in 2016 and other law firms throughout the nation often seek its experience and expertise on complex litigation.